Scholars Central

Conference abstractPublished 10 May 2018

G9a histone methyltransferase: a link between epigenetic regulation and tumour hypoxia in breast cancer

Authors: Francesco Casciello, Fares Al Ejeh, Greg Kelly, Donal J Brennan, Shin Foong Ngiow, Arabella Young, Thomas Stoll, Michelle M Hill, Mark J Smyth, Frank Gannon, Jason S Lee

QIMR Berghofer Medical Research Institute, Australia Queensland University of Technology, Australia MMUH - UCD School of Medicine, Ireland University of Queensland, Australia Diamantina Institute - University of Queensland, Australia Translational Research Institute, Australia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

G9a is an epigenetic regulator that methylates H3K9 generally causing repression of gene expression and participate in diverse cellular functions. G9a is genetically deregulated in a variety of tumour-types, and can silence tumour suppressor genes and therefore is important for carcinogenesis. Although hypoxia is recognized to be an adverse factor in tumour growth and metastasis, the role of G9a in regulating gene expression in hypoxia has not been described extensively. Here we show that G9a protein stability is increased in hypoxia via reduced proline hydroxylation and hence inefficient degradation by the proteasome. This leads to an increase in H3K9me2 at its target promoters. Blocking the methyltransferase activity of G9a inhibited cellular proliferation and migration in vitro and tumour growth in vivo. Furthermore, an increased level of G9a is a crucial factor in mediating the hypoxic response by down-regulating the expression of specific genes, including ARNTL, CEACAM7, GATA2, HHEX, KLRG1 and OGN. This down-regulation can be rescued by a small molecule inhibitor of G9a. Based on the hypothesis that the changes in gene expression would influence patient outcomes, we have developed a prognostic G9a-suppressed gene signature that can stratify breast cancer patients. Together, our findings provide a new insight into the role G9a plays as an epigenetic mediator of hypoxic response which can be used as a diagnostic marker and proposes G9a as a therapeutic target for solid cancers.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Francesco Casciello”
  • BylineArticles whose byline prints “Fares Al Ejeh”
  • BylineArticles whose byline prints “Greg Kelly”
  • BylineArticles whose byline prints “Donal J Brennan”
  • BylineArticles whose byline prints “Shin Foong Ngiow”
  • BylineArticles whose byline prints “Arabella Young”
  • BylineArticles whose byline prints “Thomas Stoll”
  • BylineArticles whose byline prints “Michelle M Hill”